Jonathan S. Dordick is Special Advisor to the President on Strategic Initiatives and Institute Professor of Chemical and Biological Engineering. Professor Dordick received his B.A. degree in Biochemistry and Chemistry from Brandeis University and his Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology. He has held chemical engineering faculty appointments at the University of Iowa (1987–1998), where he also served Associate Director of the Center for Biocatalysis and Bioprocessing, and Rensselaer (1998–present) where he also holds joint appointments in the departments of Biomedical Engineering, Materials Science and Engineering, and Biology.
Professor Dordick’s research group includes chemical engineers, bioen-gineers, materials scientists, biologists, chemists and microbiologists all focused on gaining a quantitative understanding of biological principles and applying them to advance bioengineering, nanobiotechnology, drug discovery, and biomanufacturing.
He presently serves on the Scientific Advisory Boards for several biotech-nology companies and venture capital firms, and has cofounded a number of companies, including EnzyMed (now part of Albany Molecular Research, Inc.), Solidus Biosciences, and The Paper Battery Company. Dr. Dordick has published over 370 papers and is an inventor/co-inventor on nearly 43 patents and patent applications. Most recently, Dr. Dordick was elected to the National Academy of Engineering (NAE), which is among the highest professional honors bestowed upon an engineer.
